ScanTech Identification Beam Systems, LLC Closes Business Combination with Mars Acquisition Corp. Shares of the New Public Company, ScanTech AI Systems Inc., Will Begin Trading on Nasdaq
ScanTech AI Systems Inc. announced the completion of its business combination with Mars Acquisition Corp. (MARX) on January 2, 2025. The company's common stock will begin trading on the Nasdaq Global Market under the ticker symbol 'STAI' on January 3, 2025.
The business combination, approved by Mars shareholders on December 12, 2024, positions ScanTech AI to expand its non-intrusive fixed-gantry CT screening technologies. The company aims to enhance its market presence, pursue innovation, and make its technology more accessible and intelligent.
The transition to becoming a public company is expected to enable ScanTech AI to capitalize on new growth opportunities and scale its operations globally. The company will focus on capturing potential in an expanding total addressable market while furthering its portfolio development.
ScanTech AI Systems Inc. ha annunciato il completamento della sua fusione aziendale con Mars Acquisition Corp. (MARX) il 2 gennaio 2025. Le azioni comuni della società inizieranno a essere negoziate sul Nasdaq Global Market con il simbolo 'STAI' a partire dal 3 gennaio 2025.
La fusione aziendale, approvata dagli azionisti di Mars il 12 dicembre 2024, posiziona ScanTech AI per espandere le sue tecnologie di screening CT a portale fisso non intrusivo. L'azienda punta a migliorare la sua presenza sul mercato, a perseguire l'innovazione e a rendere la sua tecnologia più accessibile e intelligente.
La transizione verso la pubblica è prevista per consentire a ScanTech AI di capitalizzare nuove opportunità di crescita e di scalare le proprie operazioni a livello globale. L'azienda si concentrerà sulla cattura del potenziale in un mercato indirizzabile totale in espansione, continuando allo stesso tempo lo sviluppo del suo portafoglio.
ScanTech AI Systems Inc. anunció la finalización de su combinación de negocios con Mars Acquisition Corp. (MARX) el 2 de enero de 2025. Las acciones comunes de la compañía comenzarán a cotizar en el Nasdaq Global Market bajo el símbolo de ticker 'STAI' el 3 de enero de 2025.
La combinación de negocios, aprobada por los accionistas de Mars el 12 de diciembre de 2024, posiciona a ScanTech AI para expandir sus tecnologías de detección por TAC fija no intrusiva. La empresa tiene como objetivo mejorar su presencia en el mercado, perseguir la innovación y hacer su tecnología más accesible e inteligente.
Se espera que la transición a convertirse en una empresa pública permita a ScanTech AI capitalizar nuevas oportunidades de crecimiento y escalar sus operaciones a nivel mundial. La compañía se centrará en captar el potencial en un mercado total direccionable en expansión, mientras continúa desarrollando su cartera.
ScanTech AI Systems Inc.는 2025년 1월 2일 Mars Acquisition Corp. (MARX)와의 사업 조합 완료를 발표했습니다. 회사의 보통주가 2025년 1월 3일부터 Nasdaq Global Market에서 'STAI'라는 심볼로 거래를 시작할 예정입니다.
2024년 12월 12일 Mars 주주들의 승인으로 이루어진 이번 사업 조합은 ScanTech AI가 비침습적 고정형 포털 CT 스크리닝 기술을 확장할 수 있는 기반을 마련합니다. 회사는 시장 존재감을 강화하고 혁신을 추구하며 기술을 보다 접근 가능하고 스마트하게 만들 계획입니다.
상장 기업으로의 전환은 ScanTech AI가 새로운 성장 기회를 활용하고 글로벌 차원에서 운영을 확대할 수 있도록 할 것으로 예상됩니다. 회사는 계속해서 포트폴리오 개발을 진행하면서 확장하는 총 주소 가능한 시장에서 잠재력을 포착하는 데 집중할 것입니다.
ScanTech AI Systems Inc. a annoncé l'achèvement de sa combinaison d'affaires avec Mars Acquisition Corp. (MARX) le 2 janvier 2025. Les actions ordinaires de l'entreprise commenceront à être négociées sur le Nasdaq Global Market sous le symbole boursier 'STAI' à partir du 3 janvier 2025.
La combinaison d'affaires, approuvée par les actionnaires de Mars le 12 décembre 2024, positionne ScanTech AI pour élargir ses technologies de dépistage CT à portique fixe non intrusif. L'entreprise vise à améliorer sa présence sur le marché, à poursuivre l'innovation et à rendre sa technologie plus accessible et intelligente.
La transition vers une entreprise publique devrait permettre à ScanTech AI de tirer parti de nouvelles opportunités de croissance et de développer ses opérations à l'échelle mondiale. L'entreprise se concentrera sur la capture du potentiel d'un marché adressable total en expansion tout en poursuivant le développement de son portefeuille.
ScanTech AI Systems Inc. gab bekannt, dass die Fusion mit Mars Acquisition Corp. (MARX) am 2. Januar 2025 abgeschlossen wurde. Die Stammaktien des Unternehmens werden ab dem 3. Januar 2025 unter dem Tickersymbol 'STAI' am Nasdaq Global Market gehandelt.
Die Fusion, die am 12. Dezember 2024 von den Mars-Aktionären genehmigt wurde, positioniert ScanTech AI, um seine nicht-invasiven CT-Screening-Technologien mit fixer Laufkatze auszubauen. Das Unternehmen strebt an, seine Marktpräsenz zu verbessern, Innovationen voranzutreiben und seine Technologie zugänglicher und intelligenter zu machen.
Der Übergang zu einem öffentlichen Unternehmen wird voraussichtlich ScanTech AI ermöglichen, neue Wachstumschancen zu nutzen und seine Aktivitäten global zu skalieren. Das Unternehmen wird sich darauf konzentrieren, Potenzial in einem wachsenden gesamtem adressierbaren Markt zu erfassen und gleichzeitig die Portfolioentwicklung voranzutreiben.
- Successful completion of business combination and uplisting to Nasdaq Global Market
- Access to public capital markets for potential future growth financing
- Enhanced ability to pursue market expansion and technological innovation
- Opportunity to scale operations globally
- None.
Insights
The SPAC merger completion between ScanTech and Mars Acquisition Corp represents a
The timing of this listing is particularly strategic, coinciding with heightened market interest in AI and security technology sectors. The fixed-gantry CT screening technology positions ScanTech uniquely in a growing market segment where non-intrusive security solutions are increasingly demanded across various sectors.
What's particularly noteworthy is the retention of key management personnel post-merger, with Dolan Falconer continuing as CEO and Karl Brenza maintaining involvement. This leadership continuity often correlates with more successful post-SPAC performance. The relatively modest market cap suggests room for growth, though investors should monitor the execution of expansion plans and cash burn rate in early public trading.
ScanTech's fixed-gantry CT screening technology represents a compelling intersection of AI and security infrastructure. The technology's non-intrusive nature addresses a critical market need while potentially reducing operational friction in security protocols. The public listing provides the capital framework needed to scale this technology and potentially accelerate R&D initiatives.
The company's emphasis on "customer-centric design" and adaptability suggests a product development strategy aligned with market demands. Their focus on expanding the total addressable market through portfolio diversification indicates potential revenue stream multiplication, important for early-stage public companies in the tech sector.
For the general public: Think of this like a sophisticated airport scanner company getting a major upgrade in its business status. Instead of having to go through traditional funding channels, they now have access to public market funding to make their security scanning technology better and more widely available.
- Business Combination between ScanTech Identification Beam Systems, LLC and Mars Acquisition Corp. closed on January 2, 2025
- Trading of common stock of the new public company, ScanTech AI Systems Inc., will commence on Nasdaq on January 3, 2025 under the ticker symbol “STAI”
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (“ScanTech AI”), today announced the successful closing of its previously announced business combination (the “Business Combination”) between ScanTech Identification Beam Systems, LLC (“ScanTech”), a provider of one of the world’s most advanced non-intrusive “fixed-gantry” CT screening technologies, and Mars Acquisition Corp. (“Mars”) (Nasdaq: MARX), a special purpose acquisition company. Mars shareholders approved the business combination at a special meeting held on December 12, 2024.
The shares of common stock of the post-combination company, ScanTech AI, are expected to begin trading under the ticker symbol “STAI” on the Nasdaq Global Market on January 3, 2025.
The Business Combination marks a significant step in ScanTech’s evolution. It will enhance ScanTech’s ability to pursue its strategic vision of innovation, adaptability, and customer-centric design. ScanTech AI will remain focused on capturing the potential of an expanding total addressable market, and plans to further expand its portfolio, making technology more accessible and intelligent.
Dolan Falconer, Chief Executive Officer of ScanTech AI, commented, “Our Nasdaq listing marks a pivotal moment in ScanTech’s evolution. As a public company, we are poised to capitalize on new growth opportunities and scale our business globally.”
Karl Brenza, Chief Executive Officer and Chief Financial Officer of Mars, stated, “We are proud to have played a key role in ScanTech’s journey to becoming a public company. ScanTech has demonstrated remarkable operations, and I have no doubt that their relentless focus on innovation and execution will continue to drive ScanTech AI’s success in the public markets. I am excited to continue to play a role in this company’s promising growth story and to have the opportunity to continue working closely together.”
VCL Law LLP served as legal counsel to Mars Acquisition Corp. Ellenoff Grossman & Schole LLP acted as legal counsel to ScanTech Identification Beam Systems, LLC.
About ScanTech AI Systems Inc.
ScanTech AI will continue the business operations of ScanTech, which has developed one of the world’s most advanced non-intrusive ‘fixed-gantry’ CT screening technologies. ScanTech utilizes proprietary artificial intelligence (AI) and machine learning capabilities in its state-of-the-art fixed- gantry CT scanners to accurately and quickly detect hazardous materials and contraband. ScanTech’s ‘fixed-gantry’ CT scanners are engineered to automatically locate, discriminate, and identify threat materials and items of interest at checkpoints in airports, seaports, borders, embassies, corporate headquarters, government & commercial buildings, factories, processing plants, and other facilities where terrorism and prohibited items are a possibility. Whether explosives or contraband, ScanTech’s ‘fixed-gantry’ CT scanners can detect, identify, precisely locate, and discriminate materials of interest hidden inside scanned targets. From suitcases, briefcases, and backpacks to large packages, and parcels, ScanTech has a non-intrusive inspection solution to meet the requirements of a broad range of critical infrastructure industries.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the U.S. Securities Exchange Act of 1934, as amended (“Exchange Act”), including statements regarding ScanTech AI’s management team’s expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future, including possible business combinations, revenue growth and financial performance, product expansion and services. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Additionally, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on the current expectations and beliefs made by the managements of ScanTech AI, ScanTech and Mars in light of their respective experience and their perception of historical trends, current conditions and expected future developments and their potential effect on ScanTech AI, as well as other factors they believe are appropriate under the circumstances. There can be no assurance that future developments affecting ScanTech AI will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including product and service acceptance, regulatory oversights, research and development success, and that ScanTech AI will have sufficient capital to operate as anticipated. Should one or more of these risks of uncertainties materialize, or should any of the assumptions of ScanTech AI prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of the filings of ScanTech AI (and its predecessor, Mars) with the SEC, and in the current and periodic reports filed or furnished by ScanTech AI (and its predecessor, Mars) from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on the information available to ScanTech AI as of the date hereof, and ScanTech AI assumes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may otherwise be required under applicable securities laws.
Contact Information:
ScanTech AI Systems Inc.
Dolan Falconer, CEO
dfalconer@scantechibs.com
Investor & Media Relations Contact:
International Elite Capital Inc.
Annabelle Zhang
+1(646) 866-7928
annabelle@iecapitalusa.com
FAQ
When will ScanTech AI Systems (STAI) begin trading on Nasdaq after the MARX merger?
What was the shareholder approval date for the ScanTech-MARX business combination?
What technology does ScanTech AI Systems specialize in?
What are ScanTech AI's post-merger business objectives?
